Biotie Therapies Corp. (CIK: 0001579695) EDGAR, Information, Filings... CompaniesBIO.Com

Biotie Therapies Corp.

Mailing address
JOUKAHAISENKATU 6, TURKU, Finland, FI-20520
Phone
358-2-274-8900
State location
Finland
State of incorporation
Finland
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

Biotie Therapies Corp. (CIK: 0001579695) is an American company incorporated in the state of Finland. Head office is located at JOUKAHAISENKATU 6, TURKU, Finland, FI-20520. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Biotie Therapies Corp. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Biotie Therapies Corp.

Filings	Format	Description	Filed/Effective	File/Film Number
CT ORDER	Document	Acc-no: 9999999997-20-002717 (33 Act) Size: KB	May-11-2020	333-204147 20864516
CT ORDER	Document	Acc-no: 9999999997-18-006977 (33 Act) Size: KB	Jul-19-2018	333-204147 18960712
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-17-033243 (34 Act) Size: KB	Feb-07-2017	001-37423 17579354
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-17-023823 (33 Act) Size: KB	Jan-30-2017	333-206484 17558427
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-016765 (34 Act) Size: KB	Sep-30-2016	001-37423 161913574
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-016564 (34 Act) Size: KB	Sep-26-2016	001-37423 161902936
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-015756 (34 Act) Size: KB	Aug-26-2016	001-37423 161855219
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-015735 (34 Act) Size: KB	Aug-25-2016	001-37423 161852153
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-015621 (34 Act) Size: KB	Aug-18-2016	001-37423 161841362
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-015108 (34 Act) Size: KB	Jul-28-2016	001-37423 161790838
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-014887 (34 Act) Size: KB	Jul-19-2016	001-37423 161773794
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-014459 (34 Act) Size: KB	Jun-30-2016	001-37423 161739846
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-014266 (34 Act) Size: KB	Jun-21-2016	001-37423 161724834
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-16-620244 (34 Act) Size: KB	Jun-13-2016	001-37423 161711261
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-014102 (34 Act) Size: KB	Jun-13-2016	001-37423 161711189
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-014077 (34 Act) Size: KB	Jun-10-2016	001-37423 161707895
25	Document	Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange Acc-no: 0001193125-16-611282 (34 Act) Size: 0 KB	Jun-02-2016	001-37423 161693134
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-013458 (34 Act) Size: KB	May-18-2016	001-37423 161661343
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0000950103-16-013318 (34 Act) Size: KB	May-12-2016	001-37423 161641650
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-16-575576 (34 Act) Size: KB	May-04-2016	005-88895 161617183

Recent 20 filings. View all Biotie Therapies Corp. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Biotie Therapies Corp. overview
Biotie Therapies Corp. job
Biotie Therapies Corp. stock
Biotie Therapies Corp. ownership
Biotie Therapies Corp. CEO
Biotie Therapies Corp. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.